Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Hanna Gyllensten

Senior lecturer

Hanna Gyllensten
Senior lecturer
hanna.gyllensten@gu.se
+46 31 786 6106
0707-482412

Room number: 1008
Postal Address: Box 457, 40530 Göteborg
Visiting Address: Arvid wallgrens backe 20 , 41346 Göteborg


Institute of Health and Care Sciences (More Information)
Box 457
405 30 Göteborg
www.caresci.gu.se
vardvetenskap@fhs.gu.se
Fax: +46 31 786 6050

Visiting Address: Arvid Wallgrens backe hus 1 O 2 , 405 30 Göteborg

About Hanna Gyllensten

About Hanna Gyllensten

Hanna Gyllensten is a registered pharmacist with a background in community pharmacy and as a ward pharmacist. She is PhD (Medicine) since 2014 and her thesis was exploring the economic impact of drug-related morbidity, including e.g., adverse drug reactions and sub-therapeutic effects of drug therapy. Hanna is now a senior lecturer at University of Gothenburg and postdoc at Insurance Medicine, Karolinska institutet in Stockholm.


Research

Hannas research focuses on health economic aspects of, in particular, chronic diseases. At University of Gothenburg she conducts economic evaluations of person-centred interventions in healthcare, based on data collected within clinical trials and complemented by data from national and regional registers.

Her other research projects include mainly (register-based) observational research. The studies uses national registers, sometimes complemented by data from population survey or collected from medical records, to study e.g., societal costs resulting from disease.


Research group

GPCC - University of Gothenburg Centre for Person-centred Care.


Education

Health economics, quantitative research methods, evidence-based public health, social pharmacy.


Key words

Health economics, person-centred care, drug-related morbidity, drug safety, pharmacoepidemiology, pharmacoeconomics, public health.

Latest publications

Comparing costs of illness of multiple sclerosis in three different years: A population-based study.
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Emilie Friberg, Jan Hillert et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2017
Journal article

Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age.
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Anders Norlund, Emilie Friberg et al.
The European journal of health economics : HEPAC : health economics in prevention and care, Journal article 2017
Journal article

Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
Andrius Kavaliunas, Ali Manouchehrinia, Virginija Danylaite Karrenbauer, Hanna Gyllensten, Anna Glaser et al.
PloS one, Journal article 2017
Journal article

Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers.
Jennie Natanaelsson, Katja M Hakkarainen, Staffan Hägg, Karolina Andersson Sundell, Max Petzold et al.
Research in social & administrative pharmacy : RSAP, Journal article 2016
Journal article

Cost-effectiveness of the behavioral antenatal care intervention programme Mighty Mums
Hanna Gyllensten, Karin Haby, Marie Berg, Åsa Premberg, Elisabeth Hansson-Olofsson
European Obesity Summit (EOS) - Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1-4, 2016. Obesity Facts., Conference paper 2016
Conference paper

Cost of illness of Multiple Sclerosis - A systematic review
Olivia Ernstsson, Hanna Gyllensten, Kristina Alexanderson, Petter Tinghög, Emilie Friberg et al.
PLoS ONE, Review article 2016
Review article

Person-centred care after acute coronary syndrome is effective in persons with lower socioeconomic position
Andreas Fors, Hanna Gyllensten, Karl Swedberg, Inger Ekman
International Forum on Quality and Safety in Healthcare, 12-15 April 2016, Gothenburg, Sweden, Poster 2016
Poster

Showing 1 - 10 of 18

2017

Comparing costs of illness of multiple sclerosis in three different years: A population-based study.
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Emilie Friberg, Jan Hillert et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2017
Journal article

Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age.
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Anders Norlund, Emilie Friberg et al.
The European journal of health economics : HEPAC : health economics in prevention and care, Journal article 2017
Journal article

Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
Andrius Kavaliunas, Ali Manouchehrinia, Virginija Danylaite Karrenbauer, Hanna Gyllensten, Anna Glaser et al.
PloS one, Journal article 2017
Journal article

2016

Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers.
Jennie Natanaelsson, Katja M Hakkarainen, Staffan Hägg, Karolina Andersson Sundell, Max Petzold et al.
Research in social & administrative pharmacy : RSAP, Journal article 2016
Journal article

Cost-effectiveness of the behavioral antenatal care intervention programme Mighty Mums
Hanna Gyllensten, Karin Haby, Marie Berg, Åsa Premberg, Elisabeth Hansson-Olofsson
European Obesity Summit (EOS) - Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1-4, 2016. Obesity Facts., Conference paper 2016
Conference paper

Cost of illness of Multiple Sclerosis - A systematic review
Olivia Ernstsson, Hanna Gyllensten, Kristina Alexanderson, Petter Tinghög, Emilie Friberg et al.
PLoS ONE, Review article 2016
Review article

Person-centred care after acute coronary syndrome is effective in persons with lower socioeconomic position
Andreas Fors, Hanna Gyllensten, Karl Swedberg, Inger Ekman
International Forum on Quality and Safety in Healthcare, 12-15 April 2016, Gothenburg, Sweden, Poster 2016
Poster

2015

Showing 1 - 10 of 18

Page Manager: Ingela Lundgren|Last update: 9/18/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?